2-151560958-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001164507.2(NEB):​c.19206+46C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0214 in 1,176,964 control chromosomes in the GnomAD database, including 325 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 61 hom., cov: 32)
Exomes 𝑓: 0.021 ( 264 hom. )

Consequence

NEB
NM_001164507.2 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.411

Publications

2 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-151560958-G-T is Benign according to our data. Variant chr2-151560958-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 257778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0248 (3765/151758) while in subpopulation AFR AF = 0.0379 (1569/41384). AF 95% confidence interval is 0.0364. There are 61 homozygotes in GnomAd4. There are 1859 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 61 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.19206+46C>A intron_variant Intron 123 of 181 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.19206+46C>A intron_variant Intron 123 of 181 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.19206+46C>A intron_variant Intron 123 of 181 5 NM_001164508.2 ENSP00000380505.3 P20929-2
NEBENST00000427231.7 linkc.19206+46C>A intron_variant Intron 123 of 181 5 NM_001164507.2 ENSP00000416578.2 P20929-3

Frequencies

GnomAD3 genomes
AF:
0.0248
AC:
3754
AN:
151640
Hom.:
61
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0377
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0122
Gnomad ASJ
AF:
0.0285
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00522
Gnomad FIN
AF:
0.0407
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0206
Gnomad OTH
AF:
0.0241
GnomAD2 exomes
AF:
0.0193
AC:
3631
AN:
188430
AF XY:
0.0187
show subpopulations
Gnomad AFR exome
AF:
0.0350
Gnomad AMR exome
AF:
0.00892
Gnomad ASJ exome
AF:
0.0200
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0355
Gnomad NFE exome
AF:
0.0224
Gnomad OTH exome
AF:
0.0221
GnomAD4 exome
AF:
0.0209
AC:
21430
AN:
1025206
Hom.:
264
Cov.:
13
AF XY:
0.0201
AC XY:
10519
AN XY:
523408
show subpopulations
African (AFR)
AF:
0.0375
AC:
910
AN:
24294
American (AMR)
AF:
0.00997
AC:
343
AN:
34396
Ashkenazi Jewish (ASJ)
AF:
0.0231
AC:
493
AN:
21372
East Asian (EAS)
AF:
0.0000268
AC:
1
AN:
37296
South Asian (SAS)
AF:
0.00688
AC:
466
AN:
67716
European-Finnish (FIN)
AF:
0.0350
AC:
1784
AN:
50930
Middle Eastern (MID)
AF:
0.00957
AC:
34
AN:
3554
European-Non Finnish (NFE)
AF:
0.0222
AC:
16462
AN:
740002
Other (OTH)
AF:
0.0205
AC:
937
AN:
45646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1052
2105
3157
4210
5262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0248
AC:
3765
AN:
151758
Hom.:
61
Cov.:
32
AF XY:
0.0251
AC XY:
1859
AN XY:
74194
show subpopulations
African (AFR)
AF:
0.0379
AC:
1569
AN:
41384
American (AMR)
AF:
0.0122
AC:
186
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.0285
AC:
99
AN:
3468
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5124
South Asian (SAS)
AF:
0.00523
AC:
25
AN:
4784
European-Finnish (FIN)
AF:
0.0407
AC:
429
AN:
10552
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0206
AC:
1400
AN:
67890
Other (OTH)
AF:
0.0238
AC:
50
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
175
350
526
701
876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0213
Hom.:
54
Bravo
AF:
0.0236

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.84
DANN
Benign
0.49
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76261031; hg19: chr2-152417472; API